These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 33491819

  • 1. Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study.
    Kagan KO, Enders M, Hoopmann M, Geipel A, Simonini C, Berg C, Gottschalk I, Faschingbauer F, Schneider MO, Ganzenmueller T, Hamprecht K.
    Ultrasound Obstet Gynecol; 2021 Apr; 57(4):560-567. PubMed ID: 33491819
    [Abstract] [Full Text] [Related]

  • 2. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
    Kagan KO, Enders M, Schampera MS, Baeumel E, Hoopmann M, Geipel A, Berg C, Goelz R, De Catte L, Wallwiener D, Brucker S, Adler SP, Jahn G, Hamprecht K.
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):383-389. PubMed ID: 29947159
    [Abstract] [Full Text] [Related]

  • 3. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.
    Blázquez-Gamero D, Galindo Izquierdo A, Del Rosal T, Baquero-Artigao F, Izquierdo Méndez N, Soriano-Ramos M, Rojo Conejo P, González-Tomé MI, García-Burguillo A, Pérez Pérez N, Sánchez V, Ramos-Amador JT, De la Calle M.
    J Matern Fetal Neonatal Med; 2019 Feb; 32(4):617-625. PubMed ID: 28978246
    [Abstract] [Full Text] [Related]

  • 4. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
    Seidel V, Hackelöer M, Rancourt RC, Henrich W, Siedentopf JP.
    Arch Gynecol Obstet; 2020 Dec; 302(6):1353-1359. PubMed ID: 32754858
    [Abstract] [Full Text] [Related]

  • 5. Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy.
    Faure-Bardon V, Fourgeaud J, Stirnemann J, Leruez-Ville M, Ville Y.
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):576-581. PubMed ID: 33998084
    [Abstract] [Full Text] [Related]

  • 6. No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: experience from a single centre.
    Chiaie LD, Neuberger P, Vochem M, Lihs A, Karck U, Enders M.
    Arch Gynecol Obstet; 2018 Jun; 297(6):1389-1395. PubMed ID: 29404743
    [Abstract] [Full Text] [Related]

  • 7. First-trimester diagnosis of congenital cytomegalovirus infection after maternal primary infection in early pregnancy: feasibility study of viral genome amplification by PCR on chorionic villi obtained by CVS.
    Faure-Bardon V, Fourgeaud J, Guilleminot T, Magny JF, Salomon LJ, Bernard JP, Leruez-Ville M, Ville Y.
    Ultrasound Obstet Gynecol; 2021 Apr; 57(4):568-572. PubMed ID: 33533526
    [Abstract] [Full Text] [Related]

  • 8. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis.
    Buxmann H, Stackelberg OM, Schlößer RL, Enders G, Gonser M, Meyer-Wittkopf M, Hamprecht K, Enders M.
    J Perinat Med; 2012 Mar 27; 40(4):439-46. PubMed ID: 22752777
    [Abstract] [Full Text] [Related]

  • 9. Revisiting short- and long-term outcome after fetal first-trimester primary cytomegalovirus infection in relation to prenatal imaging findings.
    Lipitz S, Elkan Miller T, Yinon Y, Weissbach T, De-Castro H, Hoffman C, Katorza E, Weisz B.
    Ultrasound Obstet Gynecol; 2020 Oct 27; 56(4):572-578. PubMed ID: 31858642
    [Abstract] [Full Text] [Related]

  • 10. Risk of congenital cytomegalovirus infection in children born to women with IgG avidity in the grey zone during first trimester of pregnancy.
    Kekkou K, Kavatha D, Karalexi M, Galani L, Dimopoulou D, Papaevangelou V, Antoniadou A.
    J Matern Fetal Neonatal Med; 2021 Jun 27; 34(12):2025-2029. PubMed ID: 31401915
    [Abstract] [Full Text] [Related]

  • 11. Cytomegalovirus-Specific Hyperimmune Immunoglobulin Administration for Secondary Prevention after First-Trimester Maternal Primary Infection: A 13-Year Single-Center Cohort Study.
    Karofylakis E, Thomas K, Kavatha D, Galani L, Tsiodras S, Giamarellou H, Papaevangelou V, Antoniadou A.
    Viruses; 2024 Aug 02; 16(8):. PubMed ID: 39205215
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.
    D'Antonio F, Marinceu D, Prasad S, Khalil A.
    Ultrasound Obstet Gynecol; 2023 Apr 02; 61(4):436-444. PubMed ID: 36484439
    [Abstract] [Full Text] [Related]

  • 13. Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.
    Nigro G.
    Expert Rev Anti Infect Ther; 2017 Nov 02; 15(11):977-986. PubMed ID: 29072089
    [Abstract] [Full Text] [Related]

  • 14. Cytomegalovirus infection in pregnancy.
    Yinon Y, Farine D, Yudin MH, MATERNAL FETAL MEDICINE COMMITTEE, INFECTIOUS DISEASES COMMITTEE.
    J Obstet Gynaecol Can; 2010 Apr 02; 32(4):348-354. PubMed ID: 20500943
    [Abstract] [Full Text] [Related]

  • 15. Congenital cytomegalovirus infection in twin pregnancies: viral load in the amniotic fluid and pregnancy outcome.
    Lazzarotto T, Gabrielli L, Foschini MP, Lanari M, Guerra B, Eusebi V, Landini MP.
    Pediatrics; 2003 Aug 02; 112(2):e153-7. PubMed ID: 12897321
    [Abstract] [Full Text] [Related]

  • 16. Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight.
    Nigro G, Capretti I, Manganello AM, Best AM, Adler SP.
    J Matern Fetal Neonatal Med; 2015 Jan 02; 28(2):168-71. PubMed ID: 24660895
    [Abstract] [Full Text] [Related]

  • 17. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age.
    Enders G, Daiminger A, Bäder U, Exler S, Enders M.
    J Clin Virol; 2011 Nov 02; 52(3):244-6. PubMed ID: 21820954
    [Abstract] [Full Text] [Related]

  • 18. Congenital cytomegalovirus infection following primary maternal infection in the third trimester.
    Gindes L, Teperberg-Oikawa M, Sherman D, Pardo J, Rahav G.
    BJOG; 2008 Jun 02; 115(7):830-5. PubMed ID: 18485160
    [Abstract] [Full Text] [Related]

  • 19. Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age.
    Visentin S, Manara R, Milanese L, Da Roit A, Forner G, Salviato E, Citton V, Magno FM, Orzan E, Morando C, Cusinato R, Mengoli C, Palu G, Ermani M, Rinaldi R, Cosmi E, Gussetti N.
    Clin Infect Dis; 2012 Aug 02; 55(4):497-503. PubMed ID: 22539662
    [Abstract] [Full Text] [Related]

  • 20. Neonatal and long-term outcomes of infants with congenital cytomegalovirus infection and negative amniocentesis: systematic review and meta-analysis.
    Chatzakis C, Sotiriadis A, Dinas K, Ville Y.
    Ultrasound Obstet Gynecol; 2023 Feb 02; 61(2):158-167. PubMed ID: 36412976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.